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____________________________________________________________________ 
Parkinson’s disease is the second most common neurodegenerative disorder that 
causes slowness of movement (bradykinesia), tremors and rigidity. Bradykinesia can 
present itself in multiple ways from reduced facial expression to disturbances in the 
normal gait cycle. 
 
Recent advances in neuroscience have shown that the brain is able to restructure itself 
in response to physical activity. This concept has driven the development of a new 
treatment protocol, LSVT BIG (Lee Silverman Voice Therapy BIG) that aims to tackle 
the cardinal symptom of Parkinson ’s disease: bradykinesia. 
 
The protocol is very focused on one key area of the disease. This focus is distilled into 
one verbal cue, “BIG” that is applicable to all activities of daily living. Having a spe-
cific aim and a target simplifies the process of physical therapy so that more time is 
spent on activities and relearning the proper use of one’s body and less time is spent 
cluttering the mind with words. 
 
The objective of this thesis was to design a presentation for physiotherapy students 
that introduces the basic concepts and principles and the rationale behind the LSVT 
BIG protocol. The presentation also showed what a physiotherapy student could learn 
from the LSVT BIG protocol regardless of their chosen field. The presentation was 
considered a success according to the feedback from the audience. 
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1 INTRODUCTION 
Parkinson’s disease is a condition where the dopamine producing neural pathways in 
the brain die resulting in tremors, rigidity, bradykinesia and hypokinesia. A shuffling 
gait or freeze attacks are also common characteristics of Parkinson’s disease. Neuro-
psychiatric symptoms may also be present as the disease progresses. Patients diag-
nosed with Parkinson’s disease are at a higher risk of falls and their level of activity 
and participation may suffer in the later stages.  
 
The treatment protocol of Parkinson’s disease always includes medical intervention, 
mainly Levodopa treatment. Physiotherapy is largely aimed at improving physical ca-
pacity, mobility, balance, manual activities and transfers. Bradykinesia, meaning slow 
movement, is rarely the focus of treatment. 
 
Recent advances in the field of neuroscience has given rise to the concept of neuro-
plasticity. It is known that exercise can affect brain function in a positive way. This 
concept serves as a cornerstone of the LSVT BIG protocol. The acronym “LSVT” 
comes from the words “Lee Silverman Voice Therapy”. 
 
The LSVT BIG protocol is a high intensity intervention aimed specifically at treating 
Parkinson’s disease, focusing on hypo- and bradykinesia. It is derived from the LSVT 
LOUD method used worldwide by speech therapists. The BIG protocol aims at using 
high intensity exercise daily to able the clients to modify their brain resulting in a well 
ingrained internal cue that benefits all activities of daily living. The results of this 
treatment are shown to last over three months post intervention. 
 
The author of this thesis aims to disseminate this information in Finland in order to 
raise awareness of a new tool that can be used in treating people with Parkinson’s 
disease. 
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2 PARKINSON’S DISEASE 
2.1 Definition 
Parkinson’s disease is a progressive neurodegenerative disease that is characterized by 
slowness of movement (bradykinesia), abnormal muscle rigidity and resting tremors. 
The motor symptoms of Parkinson’s disease can be explained by the loss of dopamine 
producing cells in the midbrain. The disease also causes changes in autonomic nervous 
system function and non-motor symptoms such as dysfunctions in communication, 
mood and cognition. (Stokes & Stack, 2012, 117.) Neurons are also affected in the 
peripheral nervous system, other neurotransmitter systems, the brainstem, the auto-
nomic nervous system and the cortical and subcortical structures which causes the non-
motor symptoms (Käypä hoito 2017). 
 
Primary Parkinson’s disease is idiopathic, meaning its causes are unknown. It is most 
likely caused by multiple different factors such as aging, environmental toxins and 
genes that cause neurophysiological changes in cells that produce dopamine, causing 
them to die. (Stokes & Stack, 2012, 118.) An imbalance in the secretion of dopamine 
and acetylcholine is also hypothesized to cause most of the symptoms (Tortora & Der-
rickson 2011, 630). Twelve genes have been identified and linked to Parkinson’s dis-
ease, with an earlier onset indicating the likelihood of a familial cause (Blochberger & 
Jones 2011, 361). However, a family history of Parkinson’s disease is present in only 
5%-20% of the cases and it is rarely hereditary (Tortora & Derrickson 2011, 630; Atula 
2016). Parkinson’s disease seems to be one of the very few conditions from which 
smoking seems to protect, although no means of actually preventing the disease have 
been identified (Atula 2016). 
 
Approximately 5.2 million people worldwide suffer from Parkinson’s disease. It is 
more prevalent in North America and Europe than in Africa, most likely explained by 
the difference in the average life expectancy. (Blochberger & Jones 2011, 361.) Par-
kinson’s disease is one of the most prevalent degenerative neurological conditions, 
right after Alzheimer’s disease (Yang, Tang & Guo 2016). As of 2014, approximately 
14,000 people in Finland suffer from Parkinson’s disease. Of the whole population, 1-
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2 out of a thousand have a diagnosis of Parkinson’s disease increasing up to 2 in a 
hundred among people aged 70 years or older. The disease is most prevalent among 
people 50 to 80 years of age, with men having a higher risk of getting a diagnosis. 
(Website of the Finnish Parkinson’s Association 2017).  
 
Initial symptoms of Parkinson’s disease are often unspecific such as fatigue, pain, 
weakened voice and micrographia, small handwriting. Symptoms are usually unilat-
eral at first and become bilateral as the disease progresses. Primary findings like rigid-
ity, hypokinesia and postural instability present around the moment of diagnosis. 
(Soinila, Kaste & Somer 2012, 218-219.) Parkinson’s disease also negatively affects 
the subject’s ability to swallow and control their balance, gait and limb function (Fox, 
Ebersbach, Ramig & Sapir 2012). Most common cognitive impairment is bradyphre-
nia, slowness of speech and difficulties initiating speech, and the most common neu-
ropsychiatric symptom is depression, occurring in approximately half of the cases 
(Soinila, Kaste & Somer 2012, 219). A correlation has been found between the cogni-
tive and motor impairments in Parkinson’s disease that may lead to earlier identifica-
tion of rehabilitative strategies, though further research is needed (Varalta et Al 2015). 
Both motor and non-motor symptoms have been shown to reduce the quality of life of 
people with Parkinson’s disease (Santos-García & de la Fuente-Fernández 2013; Cha-
puis et Al 2004). 
2.2 Motor Symptoms 
Bradykinesia, akinesia and hypokinesia are the most common symptoms of Parkin-
son’s disease as they manifest themselves in virtually every patient and at the early 
stages of the disease. These terms are used interchangeably, but generally refer to 
slower, smaller movements and reduced spontaneous movements such as blinking and 
smiling. This reduction in movement speed is caused by abnormal activity in many 
parallel circuitries in the basal ganglia. (Mazzoni, Shabbott & Cortés 2012). The slow-
ness and smallness of movement can appear in a multitude of different ways. Stride 
length reduces, getting up from a chair becomes more difficult and the reduced or lack 
of facial expression entirely can lead to difficulties in social interaction, for example. 
(Website of Parkinsoninfo.fi 2017). 
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Tremor is low in frequency and is present mostly in the upper limb at rest and is di-
minished during activity. The so called pill-rolling tremor is a typical form of tremor 
in the fingers. (Atula 2016). Tremor is the first symptom for every three out of four 
patients. It is one of the most common and easy to identify symptoms of Parkinson’s 
disease. Anxiety, stress and lack of sleep increase the tremor. However, a portion of 
the affected populace never experience tremors, or it can be very mild and infrequent. 
The tremor can also appear in the jaw and tongue which also affects speech. (Website 
of Parkinsoninfo.fi 2017).  
 
Rigidity can present itself as slowness in movements and it is also apparent during 
assisted movements in which the subject resists passive mobilization of the joint (Atula 
2016). Rigidity can be tested by passively moving one limb and combining it with a 
voluntary movement on the contralateral side. The test may even show signs of latent 
rigidity not apparent to the patient, who often do not complain about rigidity, but the 
ensuing functional limitations such as difficulties getting out of bed. It is suggested 
that rigidity is a result of a widespread pathology and is also correlated with a reduced 
overshoot in tracking tasks. (Baradaran et Al 2013). During active movement, in ad-
dition to the agonistic muscle the antagonistic muscles contract as well, resisting the 
wanted movement. Rigidity is often associated with muscle pain. (Website of Parkin-
soninfo.fi 2017).  
 
Postural instability is present in the later stages of the disease and is mainly caused by 
the degeneration of the systems that control balance and positioning (Atula 2016). 
Roughly half of people with Parkinson’s disease fall more than once a year (Käypä 
hoito 2017). People with Parkinson’s disease have a tendency to sway backwards, 
which is called retropulsion. This may provide difficulties in turning, standing up from 
a chair or just remaining upright. Postural instability is often tested with the pull test, 
where the subject is tugged backwards with moderate force and then their recovery is 
observed. (Website of Parkinson’s Disease Foundation 2017). The subject’s posture 
may also become deformed, especially in the neck and trunk, where both become in-
creasingly flexed. The knees and elbows may also become flexed. Postural control 
difficulties during movement may be present in the early stages of the disease and 
later, the balance reactions themselves may become impaired. (Keus et al. 2014). 
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Freezing is one of the secondary motor symptoms of Parkinson’s disease that may 
contribute to the heightened risk of falling. It is not explained by bradykinesia or ri-
gidity. The subject may have trouble stepping forward in numerous situations, such as 
starting to walk, crossing a threshold or turning. The freezing is temporary and can be 
helped with verbal cues or other strategies. (Website of Parkinson’s Disease Founda-
tion 2017). 
2.3 Non-motor Symptoms 
Parkinson’s disease is not only a motor disorder as it affects a wide variety of other 
systems such as the autonomic nervous system, cognition and sleep (Yang, Tang & 
Guo 2016). It was considered a pure motor disorder but is now considered a neuro-
degenerative multisystem disorder (Magrinelli et Al, 2016). These symptoms can often 
be unnoticed even though they pose a considerable threat to the subject’s quality of 
life and may actually appear more than a decade before the cardinal motor signs (Keus 
et al. 2014). As the disease progresses, dysfunctions of the autonomic nervous system 
can become apparent. These symptoms include sudden shifts in blood pressure, con-
stipation or incontinence, excessive sweating or lack thereof, olfactory dysfunction or 
impotence. Sleep disturbances, drowsiness and severe exhaustion can also be present. 
Cognitive impairments, especially memory problems, slowness of thinking or depres-
sion can manifest. It is seldom that one person presents with all of these symptoms. 
(Atula 2016.) People with Parkinson’s disease may be embarrassed to discuss these 
symptoms with professionals or they may be unaware that these symptoms are related 
to the disease (Keus et al. 2014). 
 
Executive dysfunction impairments result in the inability of the subject to function in 
an efficient manner in everyday life. This ailment is characterized by deficits in atten-
tion control, changing the target of attention, planning towards a goal, concentration, 
dual tasking, social interaction and resolving conflicts and making a decision. Execu-
tive functions are the core of normal, goal-oriented human behavior and encompasses 
all cognitive functions related to information processing including memorizing, plan-
ning, organizing and manipulating abstractions of time and space and inhibiting im-
proper responses to external stimulus. These ailments may affect the subject’s ability 
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to follow a rehabilitation program or the ability to take medication as prescribed. (Keus 
et al. 2014). 
2.4 Diagnosis 
Diagnosis of Parkinson’s disease is based on a clinical neurological examination where 
at least two cardinal symptoms must be identified and abnormal findings are excluded. 
The United Kingdom Parkinson’s Disease Society’s Brain Bank –criteria have resulted 
in an accuracy of over 90% in a specialized facility. Symmetrical motor symptoms, 
lack of tremor and early autonomic symptoms and falling could refer to some other 
type of parkinsonism. (Käypä Hoito 2017). Zero response to Levodopa treatment is 
also a sign of atypical parkinsonism and not Parkinson’s disease itself (Keus et al. 
2014). Brain imaging technology cannot be used to diagnose Parkinson’s disease, but 
can help exclude other diagnoses. A good response to a month-long trial of dopamin-
ergic medicine supports diagnosis. Differential diagnosis is focused on excluding 
parkinsonism caused by psychosis medication, vascular parkinsonism, multiple sys-
tem atrophy, progressive supranuclear palsy, corticobasal syndrome and Lewy body 
disease. (Käypä Hoito 2017). 
 
The probability of a misdiagnosis is 10-29% and it is especially inaccurate in the very 
early stages of the disease. Typical misdiagnosis in the early stages is due to essential 
tremor. (Käypä Hoito 2017.) People with a probable Parkinson’s disease are referred 
to a specialized neurologist for a better diagnostic accuracy (Keus et al. 2014). 
2.5 Treatment 
Medication is started as soon as the subject feels the symptoms affecting their quality 
of life. MAO-B inhibitors or dopamine agonists are usually the first choice of medica-
tion. Levodopa is considered the most effective medication for treating Parkinson’s 
disease. The aim is to find the minimal dose possible as Levodopa does not come 
without side effects. (Käypä Hoito 2017). Parkinson’s disease often requires multiple 
doses of different drugs that aim to manipulate the neurotransmitter imbalances in the 
basal ganglia, thus the adherence to medication is often quite low (Keus et al. 2014) 
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Dopamine agonists are weaker in alleviating the motor symptoms of Parkinson’s dis-
ease and will eventually require the addition of Levodopa. There is no evidence that 
dopamine agonists would be better in their treatment effect in the early stages of the 
disease than Levodopa and after two years, 40% of people with dopamine agonist as 
the first line of treatment required the addition of another type of medication, either 
MAO-B inhibitor or Levodopa. The aim is to increase the dose gradually to receive 
the most effective clinical impact, but if side effects do not enable this, another dopa-
mine agonist should be used. The most common side effects of monotherapy is drows-
iness, nausea, impulsive-compulsive behavior, orthostatic hypotension, dizziness, 
lower extremity swelling, sleep disturbaces and constipation. (Käypä Hoito 2017). 
 
MAO-B inhibitors selegiline and rasagilin are a good choice for subjects in the early 
stages of Parkinson’s disease, but their treatment effect is relatively weak and limited 
in duration. People do however tolerate these inhibitors well. If combined with sele-
gilin, the Levodopa dose can be kept low. It is also associated with less shifts in func-
tion than Levodopa, but it is equal with dopamine agonists. Selegilin treatment results 
in less side effects than dopamine agonists and the treatment is seldom terminated be-
cause of that. Rasagilin is not yet shown to have an effect on the motor complications 
caused by Levodopa or the initiation of Levodopa treatment. (Käypä Hoito 2017.) 
 
Levodopa is the most effective drug for Parkinson’s disease when compared to any 
other medication and over 40 years of clinical results have proven its effectiveness. It 
can cause nausea, loss of appetite and dizziness in the early stages of treatment, and 
increased shifts in functionality and psychological symptoms in long term treatment. 
Levodopa results in quite few side effects in addition to shifts in functionality and 
dyskinesias. In order to counter the effects the dosage is kept to the smallest possible 
one. If a subject presents with a history of psychosis, Levodopa is the safest form of 
medication. The modification of Levodopa treatment aims at reducing the daily “off” 
–stages and their duration and also to minimize the eventual effect of dyskinesia, un-
wanted chorea. This is done by splitting the medication into multiple smaller doses 
throughout the day or with the addition of a dopamine agonist for example. (Käypä 
Hoito 2017.)  
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Deep brain stimulation is a form of neurosurgery that has almost completely replaced 
any other type of surgical treatment of Parkinson’s disease. Deep brain stimulation is 
very effective in reducing shifts in motor function and dyskinesia, and improves the 
subject’s quality of life. The stimulation of the substantia nigra and the globus pallidus 
interna effects last for at least five years. It benefits most those subjects with whom 
even the optimal medication suffer from shifts in function, dyskinesias such as tremor 
or have a short duration of response to Levodopa. In general the subjects have had 
Parkinson’s disease for ten years. Substantia nigra and the globus pallidus internus are 
the most common targets of deep brain stimulation. (Käypä Hoito 2017.) 
 
The requirements are that the subject has a positive response to Levodopa. They must 
also have realistic expectations of the surgery as it does not cure the disease. They 
should be under 70 years of age, but it is not absolute. They must be able to cooperate 
during the surgery and also to learn to use the remote that comes with the device. No 
co-morbidities that would increase the level of risk for the actual operation and that 
they have had the disease for at least five years. (Käypä Hoito 2017.) 
 
Deep brain stimulation may have a negative effect on the fluency of speech, speed of 
processing information and working memory. Given the electrodes do not run through 
the nucleus caudatus, the cognitive and psychiatric effects are not exacerbated. 
There’s no remarkable difference in cognitive changes post-surgery between the glo-
bus pallidus internus and substantia nigra stimulation. Usual complications include 
infections, stroke, breaking of the device’s cords, dislocation of either the generator, 
electrodes or wires and erosion of the skin at the site of the generator. Dysartria and 
falls are also a complication. Paresthesia or diplopia may occur but they usually fade 
after the programming is finished. (Käypä Hoito 2017.) 
2.6 Rehabilitation 
There are five core areas that are to be assessed in a physiotherapy program for people 
with Parkinson’s disease according to the European Physiotherapy Guideline for Par-
kinson’s disease. These core areas are physical capacity, transfers, manual activities, 
balance and gait. (Keus et al. 2014). 
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Physical capacity consists of both the muscular and respiratory systems and physio-
therapy aims to affect these. Sufficient muscle strength, endurance, coordination and 
mobility are essential in daily life. People with Parkinson’s disease also tend to me 
more inactive than the general population. Improvements in physical capacity is sug-
gested to reduce the chance of early mortality and provide a plethora of other health 
benefits. (Keus et al. 2014). 
 
Transfers are relatively complex chains of motor functions and may become increas-
ingly difficult as the disease progresses, especially getting in and out of bed and rising 
from a chair. As fluency of movement combinations, accuracy and coordination be-
comes increasingly deficient, the ability to perform manual activities is also reduced. 
Tremor and regulation of muscle force may also affect the ability to do manual activ-
ities (Keus et al. 2014). 
 
Falls are quite common in Parkinson’s disease and may present even in the early stages 
so the training of balance becomes a key factor. They can be caused by improper pos-
tural reflexes, proprioception or range of motion for example. As a consequence, peo-
ple with Parkinson’s disease are at a higher risk of hip fractures and the rehabilitation 
takes longer and is less successful in general. Those who fall have a higher risk of 
falling again which may contribute to inactivity as the subject becomes increasingly 
afraid of moving. (Keus et al. 2014). 
 
Gait disorders are considered either continuous or episodic. Continuous impairments 
include slower and smaller strides, absence of arm swing, a stooped posture and diffi-
culties in turning. Reduced walking speed is correlated with limitations in activities of 
daily living and it is also a risk factor for mortality. Episodic impairments include fes-
tination of gait and freezing episodes. In festination, the feet are behind the center of 
their gravity and the subject takes multiple small steps, and it also refers to retropul-
sion. Freezing means the momentary inability to move the feet at all. (Keus et al. 2014). 
 
The general guideline for conventional physiotherapy is to first educate the patient 
about their condition and also physical exercise in general and the benefits thereof. 
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Motivating people with Parkinson’s disease to maintain an active lifestyle is very im-
portant. Supervised exercise in considered more effective than unsupervised exercise. 
The physiotherapy program should encompass all the core areas with the focus on high 
amplitude movement aided by audible, visual and verbal cues. In the later stages of 
the program, dual tasking and complexity should be added. Other forms of exercise 
such as dance and Tai Chi can be effective in improving certain key areas. (Keus et al. 
2014). 
3 PATHOPHYSIOLOGY AND THE BASAL GANGLIA 
The basal ganglia is a set of nuclei in the midbrain that initiate and stop movement and 
regulate unwanted actions and muscle tone (Tortora & Derrickson 2011, 550). They 
are also responsible for motor learning, behavior and emotions. They communicate 
with the cortex via two parallel pathways with opposite functions. The basal ganglia 
is associated with many movement disorders. (Lanciego, Luquin & Obeso 2012). The 
different circuitries between the basal ganglia nuclei have a wide range of purposes 
from selecting motor programs and shutting down unwanted ones and also help pre-
pare for and execute movements. They are also used for other functions such as learn-
ing, planning and executing functions. (Magrinelli et Al 2016). The major components 
of the basal ganglia are depicted in Figure 1. 
 
The basal ganglia can be divided into three different subsystems. The first one consists 
of the input nuclei that receive information from cortical, thalamic and nigral sources, 
for example. They are the caudate nucleus, putamen and accumbens nucleus. The sec-
ond one consists of the output nuclei that project information to the thalamus. They 
are the globus pallidus internus and substantia nigra pars reticulata. The last system 
resides between the first two subsystems and it consists of the globus pallidus externus 
and substantia nigra pars compacta. The system forms a loop that receives information 
from the thalamus and the cortex into the striatum, then further into the basal ganglia 
and finally back to the origin, the thalamus and the cortex. (Lanciego, Luquin & Obeso 
2012). The thalamus emits sensory and motor information to the cortex, which in turn 
initiates voluntary movements (Tortora & Derrickson 2011, 555). 
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Figure 1: All the major components of the basal ganglia system (Lanciego, Luquin & Obeso 2012). 
 
In the midbrain lies a neuromelanin pigmented area, the substantia nigra. It is the 
source of dopamine in the midbrain. (Lanciego, Luquin & Obeso 2012). Reduced out-
put of dopamine from the substantia nigra pars compacta to the striatum reduces the 
output level of the basal ganglia system and thus hinders the activity of the motor 
cortex (Mazzoni, Shabbott & Cortés 2012). The loss of these neurons in the substantia 
nigra leads to Parkinson’s disease and also bradykinesia, the central disorder. (Keus et 
al. 2014). Damage to the substantia nigra in animal models produced only bradykine-
sia, suggesting that other symptoms such as tremor and rigidity would require addi-
tional lesions. (Hallett & Khoshbin 1980). Because the projection of dopamine to the 
frontal lobes, striatum and limbic circuitries is reduced and also over time, non-dopa-
mine related brain areas are damaged, the disease has a very complex way to manifest 
in a person (Keus et al. 2014). 
4 BRADYKINESIA 
4.1 Definition 
Diagnosis of Parkinson’s disease requires the subject to present with bradykinesia 
(Website of the National Parkinson Foundation 2017). Bradykinesia is a motor symp-
tom that describes the slowness of movement. It is sometimes used as a synonymous 
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term to describe akinesia, poverty of movement and hypokinesia, smallness of move-
ment. (Berardelli, Rothwell, Thompson & Hallett 2001). It can cause difficulties with 
repetitive movements and everyday activities such as walking and buttoning a shirt 
and also decrease facial expression and the volume of speech (Website of the Parkin-
son’s Disease Foundation 2017). Daily activities take longer for people with Parkin-
son’s disease and in the later stages become more and more difficult. (Tortora & Der-
rickson 2011, 630). People with Parkinson’s disease often undershoot the initial move-
ment and follow it with additional shorter movements to reach their target (Mazzoni, 
Shabbott & Cortés 2012). The number of these additional movement trials correlates 
with increased movement distance (Mazzoni, Hristova & Krakauer 2007). People with 
Parkinson’s disease also require additional firing of normal neuronal bursts to com-
plete larger ballistic movements, for example elbow flexion in different ranges (Hallett 
& Khoshbin 1980).  
 
Even though other symptoms of Parkinson’s disease, such as rigidity may contribute 
to bradykinesia, the main deficit is insufficient utilization of muscle force at the start 
of a given movement (Berardelli, Rothwell, Thompson & Hallett 2001). The lack of 
evidence of co-occurrence suggests that for example, rigidity and bradykinesia are 
manifestations of two different deficits (Mazzoni, Shabbott & Cortés 2012; Brumlik 
& Boshes 1966). Motor motivation can also contribute as people with Parkinson’s dis-
ease subconsciously opt for lower than normal speed of movement despite being able 
to reach the same accuracy and speed as healthy subjects (Mazzoni, Hristova & Kra-
kauer 2007). Due to the way the basal ganglia are organized, it is possible that only 
one area of the subject body is affected, until all of the basal ganglia is affected (Hallett 
& Khoshbin 1980). 
4.2 Exercise and bradykinesia 
Progressive strength training has been shown to positively affect bradykinesia, im-
prove upper limb movement speed and restore parts of the normal neuronal firing in 
people with Parkinson’s disease (David et Al 2016). Low load, high velocity training 
was also shown to improve levels of bradykinesia significantly in people with Parkin-
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son’s disease during a three-month power training program (Ni, Signorile, Balachan-
dran & Potiaumpai 2016). When lifting relatively high loads, people with Parkinson’s 
disease did not exhibit bradykinesia, compared to light and medium loads, which calls 
for more research on this topic (Allen, Canning, Sherrington & Fung 2009). High in-
tensity, eccentric strength training also improved not only bradykinesia, but muscle 
force and quality of life in people with Parkinson’s disease during a 12-week study 
(Dibble, Hale, Marcus, Gerber & LaStayo 2009). 
5 LSVT BIG 
5.1 Definition 
LSVT BIG is an amplitude based treatment protocol that is used to target the motor 
symptom bradykinesia in people with Parkinson’s disease. It is founded on the LSVT 
LOUD protocol, an amplitude based program for the speech motor system. The proto-
col is based on intense daily exercise for at least a month with the goal of making the 
movements of the patients bigger and calibrate them so that they learn a simple strategy 
for movement applicable to a multitude of different situations in their daily lives. With 
calibration, the physiotherapist also aims to re-educate the sensorimotor system of their 
patient. (Website of LSVT Global 2017.) 
5.2 Principles of LSVT BIG 
The principles of the LSVT BIG protocol are aligned with some of the concepts that 
drive activity dependent neuroplasticity, structural changes in the brain due to physical 
movement. These concepts include specificity, training focus on a single target that is 
increased movement amplitude, intensity, which means using an increased dosage of 
treatment, repetition, using an increased number of repetitions both in therapy and at 
home and salience, referring to using carryover and hierarchy tasks that are meaningful 
for each individual client (Fox, Ebersbach, Ramig & Sapir 2012). 
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5.2.1 Mode of treatment 
The LSVT BIG treatment is a standardized exercise program. The dosage is four con-
secutive training sessions every week for four consecutive weeks with a total of sixteen 
sessions in a month. Repetitions for the daily exercises vary from eight to sixteen de-
pending on the task. The level of effort must be anywhere from eight to nine out of 
ten, with ten being the absolute maximum intensity. (Website of LSVT Global 2017). 
It is hypothesized that a focus on a single verbal cue and motor goal, the cognitive load 
is reduced and focusing attention on movement and movement perception would be-
come easier. (Fox, Ebersbach, Ramig & Sapir 2012). 
5.2.2 Target of treatment 
The goal of the LSVT BIG treatment is increased movement amplitude across the limb 
motor system to produce normal movement, including gait. The premise is that train-
ing amplitude as a main target would affect the mechanism that causes bradykinesia, 
insufficient muscle force when initiating movement (Berardelli, Rothwell, Thompson 
& Hallett 2001; Fox, Ebersbach, Ramig & Sapir 2012). Even though the goal is to 
increase the amplitude of movement, it is by the help of the therapist that the end result 
is not over-exaggerated movement, but movement within the normal range (Fox, 
Ebersbach, Ramig & Sapir 2012). 
5.2.3 Calibration 
People with Parkinson’s disease manifest problems in sensorimotor perception and 
may have issues recognizing their reduced movement amplitude and speed. In LSVT 
BIG, the goal is to recalibrate the client in a manner that the movements they may 
perceive as too big are in fact within the normal range of movement. This is done by 
constant feedback on the client’s movement and asking them how they feel about a 
given movement. The use of a video camera is also advised to record the client walking 
for example. The goal of the protocol is to have the client recognize the required level 
of movement amplitude to produce movements within the normal range and then have 
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them apply that amplitude habitually in every single activity of daily living. (Fox, 
Ebersbach, Ramig & Sapir 2012; Website of LSVT Global 2017). 
5.3 The protocol 
First half of the session consists of daily exercises that are high effort, intense move-
ments that are repeated every day. As the treatment progresses, these exercises may be 
modified to challenge the subject more. Most of the early sessions will be focused on 
the daily tasks. However, as treatment progresses, less time is spent on the daily tasks 
and the hierarchy tasks will take more of a priority. (Website of LSVT Global 2017.) 
 
The first tasks are maximum sustained movements that are done seated. Focus is on 
making a big effort movement that ends in a stretched position that is sustained for as 
long as possible. The stretch position is held for ten seconds, counted aloud by the 
client. (Website of LSVT Global 2017.) 
 
The second tasks are repetitive and directional movements done standing. They in-
clude stepping forward, sideways and backward with large upper limb movements in-
cluded. Final daily exercises are rocking movements, the forward rock and reach and 
the sideways rock and reach. (Website of LSVT Global 2017.) 
 
The third daily tasks are functional component movements. These are up to five exer-
cises that are derived from daily activities. Sit-to-Stand is always the first one for every 
single client. With the help of the therapist the client identifies simple components of 
these tasks which are then done with the same amount of effort and intensity as the 
aforementioned daily exercises. Each exercise is done for five repetitions. (Website of 
LSVT Global 2017.) 
 
The fourth task is called BIG walking, where the client practices using the newly 
formed big amplitude for gait training. The purpose is to take bigger steps with bigger 
arm swings, with the therapist providing first a model and then shaping the client’s 
movement so that it will big enough, but not too big. (Website of LSVT Global 2017.) 
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Second half of the treatment session is spent on Hierarchy tasks. Hierarchy tasks are 
increasingly complex tasks or sequences of tasks that are specific to the client’s goals 
and needs. The aim is to transfer the increased, rescaled level of amplitude from the 
daily exercises into an increasingly complex activity that is context specific and vari-
able. The tasks become more and more difficult week by week and the client is chal-
lenged to multi-task. Difficulty can be increased by increasing amplitude and com-
plexity, duration or with the addition of a cognitive task. (Website of LSVT Global 
2017.) All the exercises and a typical session are depicted in Figure 2. 
 
The client is also given homework which should be done once on treatment days and 
twice on non-treatment days. These sessions take approximately 15 to 20 minutes and 
include all the daily exercises for half the volume, the functional component tasks, 
BIG walking and a carryover assignment. A carryover assignment is a daily task where 
the client uses big amplitude to override slow movements so that they may complete 
this task in the future independently. (Website of LSVT Global 2017.) 
 
Table 1: Outline of a typical therapy session in LSVT BIG. 
*Number of exercises  
Name of ex. Position Aim Reps & Sets Time spent 
Max sustained Seated Use BIG ampli-
tude 
16 per exercise 
(2)* 
 
Repetitive & Di-
rectional 
Standing Use BIG ampli-
tude 
20 per exercise 
(5)* 
 
Functional compo-
nents 
Varies Apply BIG to 
small daily tasks 
5 per exercise 30-45 minutes for 
all daily tasks 
BIG walking Walking Apply BIG to gait 
training 
 5-10 minutes  
Hierarchy tasks Varies Apply BIG to com-
plex movement se-
quence 
 15-30 minutes 
20 
6 AIM AND OBJECTIVE OF THE THESIS 
The objective of this thesis is to prepare a presentation to physiotherapy students that 
introduces the LSVT BIG protocol using the most recent evidence based knowledge 
of Parkinson’s disease and the LSVT principle within the context of brady- and 
hypokinesia. 
 
The aim is to disseminate this information around Finland and raise awareness of a 
new type of intervention that would improve the physical capabilities of people with 
Parkinson’s disease. 
7 THE PRESENTATION 
The presentation was included in the classes’ timetables and it was held in the new 
SAMK campus in Pori the 12th of October 2017, which their teacher had reserved and 
scheduled for the author. An hour and a half was reserved for the entire presentation. 
There was no time reserved for questions, instead, the students were able to ask ques-
tions whenever they wanted. The presentation began with the students showing 
whether or not they were especially interested in neurological physiotherapy. This was 
done by a show of hand and there were no students specifically interested in the topic.  
 
The key points of the lecture were in order the importance of having multiple perspec-
tives, the pathology and clinical manifestations of bradykinesia and finally the LSVT 
BIG protocol. The LSVT BIG protocol was not the focus of the lecture, instead, the 
author’s view on the perspective of LSVT, how the patient is seen in LSVT BIG and 
how this differs from the conventional method in physiotherapy in Finland today and 
why it is important to handle multiple perspectives was the central idea.  
7.1 Feedback 
No formal feedback was asked. Instead, at the end of the lecture, after all the questions, 
the author asked the audience to provide some form of feedback on the presentation. 
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Most of the feedback was very positive. Most people said it was the author’s enthusi-
asm, vivid language and multiple examples from real life that made the lecture inter-
esting even though they were not interested in the topic in the first place. Also the 
depth of knowledge on the author’s part was apparent and one student felt inspired to 
change their own thesis topic. It was also mentioned that the lecture pace was relatively 
slow, and the topic was handled incredibly thoroughly which, given the audience, 
could have been made slightly faster, for certain groups most likely will know the 
importance of perspective and the anatomy of the central nervous system to name a 
few.  
8 THESIS PROCESS 
8.1 Choosing a thesis type 
This thesis is focused on the operational aspects. Such a thesis aims to respond to a 
practical need or problem by designing for example events, exhibitions, fairs and re-
lated planning and organization, marketing campaigns or computer programs to name 
a few. (Hakala 2004, 23-27; Vilkka & Airaksinen 2004, 9-15.) The initial method was 
writing a journal article. However, this proved to be an unpleasant endeavor and it was 
concluded that the author is more competent in presenting the topic to a live audience 
verbally instead of through text. 
 
It is good to start planning a thesis by getting to know the subject matter and reading 
previously written text to formulate an individual perspective and an opinion on the 
subject. It is also important to determine the objective of the thesis so that it is con-
sistent with the demand. (Hakala 2004, 23-27.) A well-designed plan eases the writing 
process and the progression of a thesis. A thorough examination of a subject enables 
the author to design a good project (Vilkka & Airaksinen 2004, 9-15). 
 
The author noticed a demand for such a lecture in 2015 when they learned about the 
LSVT BIG protocol. At the time there were no LSVT certified physiotherapists in 
Finland. This was surprising as there is a lot of evidence supporting the impact of high 
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amplitude exercise on bradykinesia. More importantly, the impact of bradykinesia on 
the quality of life of a person with Parkinson’s disease is well documented, but the 
means of affecting it in the guidelines for example is very limited. The author wanted 
to spread this information as best as they could around Finland, and.  
 
The author was certified to administer LSVT BIG in March 2017 and the planning of 
the lecture began in June 2017. It should be noted that the lecture follows a very similar 
structure to that of the unpublished article so it could be said the planning of the frame-
work began as early as January 2015.  
 
Amassing the theoretical basis for the entire thesis was done over a period of 4 months, 
starting from January 2017. The sources were numbered and the topic had to be nar-
rowed down significantly in order to fit the general brackets of a bachelor’s level the-
sis. Most of the effort was spent on refining and planning the lecture itself. This was 
done through multiple conversations with people of all backgrounds aging from 21 to 
26 and rehearsals recorded on a smartphone. The author wanted the lecture to be struc-
tured enough so that it would not stray from the topic itself, but alive enough in the 
sense that it could be shaped and modified on the go depending on the audience’s 
responses and reactions to items in the lecture. Thus, the power point presentation that 
was made to support the lecture was very minimal containing only three sentences per 
slide on average, and mainly pictures. This would enable the author to stay in topic 
and reduce any additional cognitive load on the audience allowing them to fully con-
centrate on the speech element.  
8.2 Target audience 
The target audience were the third year physiotherapy classes of SAMK with the other 
being an international class with people whose native language is not Finnish, thus the 
lecture was held in English as all the students were competent enough to listen. This 
also meant the language used by the author was simplified to the degree that everyone 
would understand as much as possible.  
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9  DISCUSSION 
9.1 Evaluation of the process 
The process of writing this thesis was an incredible exercise in critical thinking. Not 
only was it necessary to gather data on a topic that is not widely discussed in the con-
text of Parkinson’s disease, bradykinesia, but also present it in a way that is interesting 
to an audience that is by default not interested in or aware of the topic. The applicabil-
ity of this experience in the future is immense as sometimes for a physiotherapist it 
will be necessary to discuss uncomfortable and novel ideas with a client for example. 
It was also of great importance to read data on the LSVT BIG protocol and Parkinson’s 
disease in a manner that would help build a pattern of thinking about any topic in 
physiotherapy, hence the numerous examples of real life experiences using multiple 
view points on any given issue. This made it so that the audience gained tools that are 
useful no matter what branch of the medical field they decide to focus on. 
 
The lecture lasted an hour and 25 minutes which was within the time frame set by the 
teacher. Most of this was spent on the lecture itself and there were not as many ques-
tions. It could be that most of the students were uncomfortable asking questions in 
English given their Finnish background, or that the topic was very novel. However, 
the questions became more abundant as the lecture progressed. 
 
The powerpoint functioned well as a figurative spine for the lecture, but it was clear 
that using the powerpoint itself should have been practiced more. There were a few 
times were the author forgot the next slide, but it was not a significant issue. The lec-
ture overall was very fluid and after the first ten minutes of nervousness the lecture 
started to flow well. It was also very interesting from the author’s point of view to see 
the students’ reactions to certain examples from popular culture and physiotherapy as 
that allowed for some improvised change in the way of presenting the topic at hand. 
 
As mentioned earlier, the importance of having multiple perspectives on a given topic 
was one of the key points of the lecture. The author thinks they provided more than 
enough examples from a wide variety of fields of science and culture on most of the 
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ideas discussed and this also made the students interested in the topic. There was also 
quite a lot of laughter at times so the lecture was humorous as well and in that regard, 
a success. 
 
In the author’s mind, the LSVT BIG protocol itself could have been explained much 
more thoroughly than it was. There is a reason why it was not the focal point of the 
lecture and these reasons are explained in the next part of this thesis report. However, 
the way the exercises can be adapted could have been explained better. There was also 
some confusion regarding the BIG movements. One student thought of BIG move-
ments as making movements that are “as BIG as possible”, when the goal of the pro-
tocol itself is to make movements that a normal in range of motion, but BIG in the 
mind of the subject with an impaired proprioceptive system. 
 
There could have been a method of gathering feedback from the students in the form 
of a questionnaire for example to provide raw data on how they experienced the lec-
ture, what they thought was thought provoking for a physiotherapy student and what 
could have been improved given the audience consists of physiotherapy students. This 
would help the author design the lecture better for said audience if it is presented again 
sometime in the future. 
9.2 Ethics and credibility 
The reasons that LSVT BIG was not reviewed more thoroughly in this thesis are many. 
First of all, the author of this thesis has never had the ability to administer the entire 
protocol to a single client which would make it disingenuous to present views and 
experiences of whether or not this protocol is good and what type of client would ben-
efit most from it. The focus was on what a student can learn from getting certified in 
LSVT BIG and the method of approaching a client in LSVT BIG as that is something 
the author has firsthand experience of. The importance of finding a common nominator 
and distilling it into a point of extreme focus was the underlying theme of the presen-
tation. 
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Second reason for not presenting LSVT BIG in a detailed manner is that currently in 
the Finnish healthcare system, there are very limited possibilities of even attempting 
to administer the entire protocol to a client as this brings up the question: “Who is 
going to pay for it?” It is still very novel an approach to the treatment of Parkinson’s 
disease and it has limited evidence supporting its efficacy which means most clients 
would have to pay for it themselves, and that would require incredible ability to per-
suade the possible clients. The LSVT BIG is also said to provide the best benefits for 
people with Parkinson’s disease who are recently diagnosed or whose condition has 
not progressed very far. In Finland, the people with Parkinson’s disease who are hos-
pitalized or sent to a rehabilitation facility have their condition progressed to the degree 
that the LSVT BIG protocol would not be as efficient as possible as a treatment tool. 
9.3 Conclusions 
To bring LSVT BIG to the forefront of rehabilitation for people with Parkinson’s dis-
ease in Finland would require a great paradigm shift in the overall approach. It would 
be necessary to go from a maintaining approach to a high intensity approach with the 
goal of drastically improving the physical capacity of the people with Parkinson’s dis-
ease.  
 
The author is not trying to judge the conventional physiotherapy approach as it does 
provide good results for a lot of the clients. However, there are people who are willing 
to participate and would benefit more from very intense programming, and this is not 
provided currently in Finland on a large scale, or a default option. 
 
Thus, the author of this thesis finds it important to understand the fundamental mode 
of thinking when administering the LSVT BIG protocol and to find patterns and prin-
ciples that can be applied one way or another to other forms of therapy. The goal is to 
use it as an example of a new way of thinking about rehabilitation and bringing to light 
a point of view that could lead to the aforementioned paradigm shift and a better se-
lection of rehabilitation methods for all people affected by Parkinson’s disease. 
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